Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gastrointestinal 1

Conditions

Rectal Neoplasms 1Pain, Postoperative 1Ileus 1Diverticulosis, Colonic 1Diverticulitis, Colonic 1Constipation 1Colonic Neoplasms 1Agnosia 1

Interventions

Fluorouracil 267Oxaliplatin 266Capecitabine 224Leucovorin 209Irinotecan 151Radiotherapy 131Bevacizumab 112Cetuximab 81Folfox protocol 48Surgical Procedures, Operative 44Radiation 41Drug Therapy 41Neoadjuvant Therapy 40Chemoradiotherapy 33Chemotherapy, Adjuvant 32Panitumumab 27XELOX 25Magnetic Resonance Spectroscopy 22Radiotherapy, Intensity-Modulated 21Floxuridine 17Biopsy 16Nivolumab 15Gemcitabine 15Early Intervention, Educational 15pembrolizumab 14Laparoscopy 14IFL protocol 14Celecoxib 14trifluridine tipiracil drug combination 13Gene Expression Profiling 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Rectal Neoplasms × Orphenadrine × Clear all
NCT02958566 2017-03-20

Multimodal Narcotic Limited Perioperative Pain Control With Colorectal Surgery

University of Illinois College of Medicine at Peoria

Phase 4 Unknown
80 enrolled
GastrointestinalOther

Agnosia, Colonic Neoplasms, Constipation, Diverticulitis, Colonic, Pain, Postoperative, Rectal Neoplasms, Diverticulosis, Colonic, Ileus

Data powered by HemOnc (CC BY 4.0) Colophon âš¡